ArticleJournal of diabetes investigation2025

Post-hoc analysis of the tofogliflozin post-marketing surveillance study (J-STEP/LT): Tofogliflozin improves liver function in type 2 diabetes patients regardless of BMI.

Hiroyuki Uchinuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.